Forte Biosciences Inc. buy stratec
Start price
19.12.18
/
50%
€113.92
Target price
20.12.18
€323.37
Performance (%)
-5.05%
End price
20.12.18
€108.17
Summary
This prediction ended on 20.12.18 with a price of €108.17. With a performance of -5.05%, the BUY prediction for Forte Biosciences Inc. by stratec closed slightly in the red. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Forte Biosciences Inc. | 12.500% | 12.500% | -61.342% | -98.726% |
| iShares Core DAX® | 1.665% | 0.362% | 17.556% | 15.301% |
| iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% | 36.536% |
| iShares Nikkei 225® | 2.620% | 1.174% | 17.273% | 10.880% |
| iShares S&P 500 | -0.091% | -1.597% | 24.739% | 36.919% |
Comments by stratec for this prediction
In the thread Tocagen diskutieren
stratec stimmt der Buy-Einschätzung von tamam zu
stratec stimmt am 19.12.2018 der Buy-Einschätzung von tamam mit dem Kursziel 23,9$ zu.
Überschrift: Tocagen: Highly Promising And Deeply Undervalued Biotech
(Stop Loss Kurs erreicht)